title: Does Trastuzumab cause permanent severe mitral regurgitation?
authors.affiliation: Ordu University, Department of Cardiology, Ordu, Turkey. Electronic address: doktorzeki28@gmail.com.
authors.forename: Zeki Yüksel
authors.initials: ZY
authors.lastname: Günaydın
authors.affiliation: Ordu University, Department of Cardiology, Ordu, Turkey.
authors.forename: Osman
authors.initials: O
authors.lastname: Bektaş
authors.affiliation: Ordu University, Department of Oncology, Ordu, Turkey.
authors.forename: Aydın
authors.initials: A
authors.lastname: Çiltaş
authors.affiliation: Giresun University, Department of Cardiology, Giresun, Turkey.
authors.forename: Ahmet
authors.initials: A
authors.lastname: Karagöz
authors.affiliation: Ordu University, Department of Cardiology, Ordu, Turkey.
authors.forename: Ahmet
authors.initials: A
authors.lastname: Kaya
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D018275:Carcinoma, Lobular / Q000188:drug therapy*; D004452:Echocardiography; D005260:Female; D006801:Humans; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000139:chemically induced* / Q000000981:diagnostic imaging; D012720:Severity of Illness Index; D000068878:Trastuzumab / Q000009:adverse effects* / Q000627:therapeutic use; D016277:Ventricular Function, Left / Q000187:drug effects*
chemical_list: D000970:Antineoplastic Agents; D000068878:Trastuzumab
keywords: Breast cancer; Echocardiography; Mitral regurgitation; Trastuzumab